Vestmark Advisory Solutions’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$730K Buy
+1,877
New +$730K 0.01% 555
2023
Q3
Sell
-7,447
Closed -$3.31M 547
2023
Q2
$3.31M Buy
7,447
+496
+7% +$220K 0.13% 210
2023
Q1
$3.2M Buy
6,951
+1,078
+18% +$496K 0.14% 199
2022
Q4
$3.01M Sell
5,873
-103
-2% -$52.8K 0.15% 193
2022
Q3
$2.72M Buy
5,976
+1,215
+26% +$552K 0.15% 190
2022
Q2
$2.3M Sell
4,761
-51
-1% -$24.6K 0.13% 208
2022
Q1
$2.36M Buy
4,812
+2,976
+162% +$1.46M 0.13% 204
2021
Q4
$851K Buy
1,836
+58
+3% +$26.9K 0.05% 399
2021
Q3
$663K Buy
1,778
+305
+21% +$114K 0.04% 415
2021
Q2
$562K Buy
1,473
+71
+5% +$27.1K 0.04% 445
2021
Q1
$503K Sell
1,402
-42
-3% -$15.1K 0.04% 439
2020
Q4
$464K Sell
1,444
-258
-15% -$82.9K 0.05% 373
2020
Q3
$457K Sell
1,702
-215
-11% -$57.7K 0.06% 339
2020
Q2
$504K Buy
1,917
+97
+5% +$25.5K 0.08% 302
2020
Q1
$413K Buy
+1,820
New +$413K 0.08% 296
2019
Q4
Sell
-1,484
Closed -$356K 336
2019
Q3
$356K Sell
1,484
-77
-5% -$18.5K 0.06% 372
2019
Q2
$441K Buy
1,561
+99
+7% +$28K 0.08% 308
2019
Q1
$420K Buy
+1,462
New +$420K 0.07% 315